In vitro assessment of antibody-conjugated gold nanorods for systemic injections

Journal of Nanobiotechnology

Volumn 12, Issue 1, 2014, Pages

  Centi, Sonia ^a   Tatini, Francesca ^b   Ratto, Fulvio ^b   Gnerucci, Alessio ^a   Mercatelli, Raffaella ^a   Romano, Giovanni ^a   Landini, Ida ^a   Nobili, Stefania ^a   Ravalli, Andrea ^a   Marrazza, Giovanna ^a   Mini, Enrico ^a   Fusi, Franco ^a   Pini, Roberto ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IFAC CNR   (Italy)

Author keywords

Active targeting; Blood compatibility; Cancer antigen 125; Competitive assay; Gold nanorods; Matrix effect

Indexed keywords

ANTIGENS; BIOCOMPATIBILITY; BIOLOGY; BLOOD; DISEASES; GOLD; INFRARED DEVICES; NANORODS; PLASMONS; TUMORS;

ACTIVE TARGETING; BLOOD COMPATIBILITY; CANCER ANTIGEN 125; COMPETITIVE ASSAYS; GOLD NANOROD; MATRIX EFFECTS;

ANTIBODIES;

ANTIBODY CONJUGATE; CA 125 ANTIGEN; CETRIMIDE; GOLD NANOPARTICLE; ANTIBODY; ANTINEOPLASTIC AGENT; GOLD; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; NANOTUBE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; FEMALE; HELA CELL LINE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDRODYNAMICS; IMMUNOASSAY; IN VITRO STUDY; LIGHT SCATTERING; LIMIT OF DETECTION; MACROPHAGE; OVARIAN CANCER CELL LINE; PHAGOCYTE; PRECIPITATION; REACTION ANALYSIS; SILVER STAINING; SPECTROPHOTOMETRY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; IMMUNOBLOTTING; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; PRECLINICAL STUDY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; CELL LINE, TUMOR; CETRIMONIUM COMPOUNDS; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; FEMALE; GOLD; HUMANS; IMMUNOBLOTTING; INJECTIONS, INTRAVENOUS; MACROPHAGES; MEMBRANE PROTEINS; MICE; NANOTUBES; OVARIAN NEOPLASMS;

EID: 84924904306     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-014-0055-3     Document Type: Article

References (71)

1. Mladenov E, Magin S, Soni A, Iliakis G: DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol 2013, 10:113.
2. Paulides MM, Stauffer PR, Neufeld E, Maccarini PF, Kyriakou A, Canters RA, Diederich CJ, Bakker JF, Van Rhoon GC: Simulation techniques in hyperthermia treatment planning. Int J Hyperthermia 2013, 19:346-357.
3. Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM: Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 2008, 60:977-985.
4. Ibsen S, Schutt CE, Esener S: Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment. Drug Des Devel Ther 2013, 7:375-388.
5. Tiwari PM, Vig K, Dennis VA, Singh SR: Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1:31-63.
6. Alkilany AM, Murphy CJ: Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12:2313-2333.
7. Jeong EH, Jung G, Hong CA, Lee H: Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications. Arch Pharm Res 2014, 37:53-59.
8. Khan MS, Vishakante GD, Siddaramaiah H: Gold nanoparticles: a paradigm shift in biomedical applications. Adv Colloid Interface Sci 2013, 199-200:44-58.
9. Papasani MR, Wang G, Hill RA: Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomed Nanotech Biol Med 2012, 8:804-814.
10. Tatini F, Landini I, Scaletti F, Massai L, Centi S, Ratto F, Nobili S, Romano G, Fusi F, Messori L, Mini E, Pini R: Size dependent biological profiles of PEGylated gold nanorods. J Mater Chem B 2014, 2:6072-6080.
11. Fang J, Chen YC: Nanomaterials for photohyperthermia: a review. Curr Pharm Des 2013, 19:6622-6634.
12. Melancon MP, Zhou M, Li C: Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011, 44:947-956.
13. Jain PK, Huang X, El-Sayed IH, El-Sayed MA: Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 2008, 41:1578-1586.
14. Young JK, Figueroa ER, Drezek RA: Tunable nanostructures as photothermal theranostic agents. Ann Biomed Eng 2012, 40:438-459.
15. Choi KY, Liu G, Lee S, Chen X: Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 2012, 4:330-342.
16. Ghosh P, Han G, De M, Kim CK, Rotello VM: Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60:1307-1315.
17. Chen H, Shao L, Li Q, Wang J: Gold nanorods and their plasmonic properties. Chem Soc Rev 2013, 42:2679-2724.
18. Ratto F, Matteini P, Rossi F, Pini R: Size and shape control in the overgrowth of gold nanorods. J Nanopart Res 2010, 12:2029-2036.
19. Li N, Zhao P, Astruc D: Anisotropic gold nanoparticles: synthesis, properties, applications, and toxicity. Angew Chem Int Ed Engl 2014, 53:1756-1789.
20. Alkilany AM, Thompson LB, Boulos SP, Sisco P, Murphy CJ: Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012, 64:190-199.
21. Zhang Z, Wang J, Chen C: Gold nanorods based platforms for light-mediated theranostics. Theranostics 2013, 3:223-238.
22. Choi WI, Sahu A, Kim YH, Tae G: Photothermal cancer therapy and imaging based on gold nanorods. Ann Biomed Eng 2012, 40:534-546.
23. Wang Y, Black KCL, Luehmann H, Li W, Zhang Y, Cai X, Wan D, Liu SY, Li M, Kim P, Li ZY, Wang LV, Liu Y, Xia Y: Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 2013, 7:2068-2077.
24. Jokerst JV, Cole AJ, Van de Sompel D, Gambhir SS: Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via raman imaging in living mice. ACS Nano 2012, 6:10366-10377.
25. Kennedy LC, Bear AS, Young JK, Lewinski NA, Kim J, Foster AE, Drezek RA: T cells enhance gold nanoparticle delivery to tumors in vivo. Nanoscale Res Lett 2011, 6:283.
26. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC: Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 2009, 9:1909-1915.
27. Von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN: Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009, 69:3892-3900.
28. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y: PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 2006, 114:343-347.
29. Rayavarapu RG, Petersen W, Hartsuiker L, Chin P, Janssen H, van Leeuwen FWB, Otto C, Manohar S, van Leeuwen TG: In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology 2010, 21:145101.
30. Joshi PP, Yoon SJ, Hardin WG, Emelianov S, Sokolov KV: Conjugation of antibodies to gold nanorods through Fc portion: synthesis and molecular specific imaging. Bioconjug Chem 2013, 19:878-888.
31. Lee E, Hong Y, Choi J, Haam S, Suh JS, Huh YM, Yang J: Highly selective CD44-specific gold nanorods for photothermal ablation of tumorigenic subpopulations generated in MCF7 mammospheres. Nanotechnology 2012, 23:465101.
32. Charan S, Sanjiv K, Singh N, Chien FC, Chen YF, Nergui NN, Huang SH, Kuo CW, Lee TC, Chen P: Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation. Bioconjug Chem 2012, 23:2173-2182.
33. Wang J, Sefah K, Altman MB, Chen T, You M, Zhao Z, Huang CZ, Tan W: Aptamer-conjugated nanorods for targeted photothermal therapy of prostate cancer stem cells. Chem Asian J 2013, 10:2417-2422.
34. Wang J, Zhu G, You M, Song E, Shukoor MI, Zhang K, Altman MB, Chen Y, Zhu Z, Huang CZ, Tan W: Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano 2012, 6:5070-5077.
35. Yang X, Liu X, Liu Z, Pu F, Ren J, Qu X: Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater 2012, 24:2890-2895.
36. Heidari Z, Sariri R, Salouti M: Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer. J Photochem Photobiol B 2013, 130:40-46.
37. Bartneck M, Ritz T, Keul HA, Wambach M, Bornemann J, Gbureck U, Ehling J, Lammers T, Heymann F, Gassler N, Lüdde T, Trautwein C, Groll J, Tacke F: Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano 2012, 6:8767-8777.
38. Wang J, Dong B, Chen B, Jiang Z, Song H: Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods. Dalton Trans 2012, 41:11134-11144.
39. Yang X, Liu Z, Li Z, Pu F, Ren J, Qu X: Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy. Chemistry 2013, 19:10388-10394.
40. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A: Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2007, 2:125-132.
41. Tong L, Wei QS, Wei A, Cheng JX: Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol 2009, 85:21-32.
42. Lu W, Zhang GD, Zhang R, Flores LG, Huang Q, Gelovani JG, Li C: Tumor site-specific silencing of NF-kappa B p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res 2010, 70:3177-3188.
43. Eghtedari M, Liopo AV, Copland JA, Oraevsky AA, Motamedi M: Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett 2009, 9:287-291.
44. Huang XH, Peng XH, Wang YQ, Wang YX, Shin DM, El-Sayed MA, Nie SM: A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4:5887-5896.
45. Ungureanu C, Kroes R, Petersen W, Groothuis TAM, Ungureanu F, Janssen H, van Leeuwen FWB, Kooyman RPH, Manohar S, van Leeuwen TG: Light interactions with gold nanorods and cells: implications for photothermal nanotherapeutics. Nano Lett 2011, 11:1887-1894.
46. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR, Karmen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992, 52:3396-3401.
47. Saul JM, Annapragada AV, Bellamkonda RV: A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Rel 2006, 114:277-287.
48. Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q: Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Rel 2010, 141:183-192.
49. Kluza E, van der Schaft DWJ, Hautvast PAI, Mulder WJM, Mayo KH, Griffioen AW, Strijkers GJ, Nicolay K: Synergistic targeting of alpha(v)beta(3) integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett 2010, 10:52-58.
50. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S: In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nature Biotechnology 2008, 26:83-90.
51. Shah NB, Vercellotti GM, White JG, Fegan A, Wagner CR, Bischof JC: Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharmaceutics 2012, 9:2146-2155.
52. Grabarek Z, Gergely J: Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131-135.
53. Das M, Mordoukhovski L, Kumacheva E: Sequestering gold nanorods by polymer microgels. Adv Mater 2008, 20:2371-2375.
54. Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA: Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008, 269:57-66.
55. Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G: Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano 2011, 5:1995-2003.
56. Bagley AF, Hill S, Rogers GS, Bhatia SN: Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source. ACS Nano 2013, 7:8089-8097.
57. Mercatelli R, Romano G, Ratto F, Matteini P, Centi S, Cialdai F, Monici M, Pini R, Fusi F: Quantitative measurement of scattering and extinction spectra of nanoparticles by darkfield microscopy. Appl Phys Lett 2011, 99:131113.
58. Mercatelli R, Ratto F, Centi S, Soria S, Romano G, Matteini P, Quercioli F, Pini R, Fusi F: Quantitative readout of optically encoded gold nanorods using an ordinary dark-field microscope. Nanoscale 2013, 5:9645.
59. Tatini F, Ratto F, Centi S, Landini I, Nobili S, Witort E, Fusi F, Capaccioli S, Mini E, Pini R: Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia. Proc. SPIE 2014, 8955:895519.
60. Ratto F, Witort E, Tatini F, Centi S, Lazzeri L, Carta F, Lulli M, Vullo D, Fusi F, Supuran CT, Scozzafava A, Capaccioli S, Pini R: Plasmonic particles that hit hypoxic cells. Adv Funct Mater 2014, doi:10.1002/adfm.201402118.
61. Rayavarapu RG, Petersen W, Ungureanu C, Post JN, van Leeuwen TG, Manohar S: Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. Int J Biomed Imag 2007, 2007:29817.
62. Kim D, Jeong YY, Jon S: A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4:3689-3696.
63. Carpin LB, Bickford LR, Agollah G, Yu TK, Schiff R, Li Y, Drezek RA: Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast Cancer Res Treat 2011, 125:27-34.
64. England CG, Priest T, Zhang G, Sun X, Patel DN, McNally LR, van Berkel V, Gobin AM, Frieboes HB: Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles. Int J Nanomed 2013, 8:3603-3617.
65. Yao L, Daniels J, Moshnikova A, Kuznetsov S, Ahmed A, Engelman DM, Reshetnyak YK, Andreev OA: pHLIP peptide targets nanogold particles to tumors. Proc Natl Acad Sci USA 2013, 110:465-470.
66. Nikoobakht B, El-Sayed MA: Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Mater 2003, 15:1957-1962.
67. Zhang G, Yang Z, Lu W, Zhang R, Huang Q, Tian M, Li L, Liang D, Li C: Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomater 2009, 30:1928-1936.
68. Pérez-Juste J, Pastoriza-Santos I, Liz-Marzán LM, Mulvaney P: Gold nanorods: synthesis, characterization and applications. Coord Chem Rev 2005, 249:1870-1901.
69. Ratto F, Matteini P, Cini A, Centi S, Rossi F, Fusi F, Pini R: CW laser-induced photothermal conversion and shape transformation of gold nanodogbones in hydrated chitosan films. J Nanopart Res 2011, 13:4337-4348.
70. Matteini P, Ratto F, Rossi F, de Angelis M, Cavigli L, Pini R: Hybrid nanocomposite films for laser-activated tissue bonding. J Biophotonics 2012, 5:868-877.
71. Etchegoin PG, Le Ru EC, Meyer M: An analytic model for the optical properties of gold. J Chem Phys 2006, 125:164705.